Novacyt: Covid-19 test approved in UK
(CercleFinance.com) - Novacyt has announced that its Covid-19 Direct Real-Time PCR assay has been approved in the UK under the Medical Devices Safety Agency (MDSA) Regulation 2021.
Designed to detect a SARS-CoV-2 gene target within ORF1ab, the test removes the need for manual or automated extraction solutions to significantly improve laboratory workflow and reduce costs.
In addition, it can be used on an open platform and therefore Novacyt's q16 and q32 instruments, as well as other validated systems. The assay is the company's fifth PCR product to be listed on the CTDA's Register of Approved Products.
Copyright (c) 2022 CercleFinance.com. All rights reserved.